Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenue:        
Contract revenue $ 13 $ 660 $ 225 $ 1,530
Costs and expenses:        
Research and development 425 904 1,508 1,897
General and administrative 537 628 1,788 1,883
Total costs and expenses 962 1,532 3,296 3,780
Loss from operations (949) (872) (3,071) (2,250)
Interest expense 0 0 0 (285)
Net loss (949) (872) (3,071) (2,535)
Deemed dividend on Series C preferred stock 0 0 0 2,486
Net loss attributable to common stockholders $ (949) $ (872) $ (3,071) $ (5,021)
Net loss per weighted share attributable to common stockholders:        
Basic (Note E) $ (0.01) $ (0.01) $ (0.02) $ (0.03)
Diluted (Note E) $ (0.01) $ (0.01) $ (0.02) $ (0.03)
Weighted average common shares outstanding:        
Basic (Note E) 152,086 151,652 152,086 147,521
Diluted (Note E) 152,086 151,652 152,086 147,521